Entity dossier

astrazeneca bristol myers squibb

1 recorded attention episode across US.

At a glance

The dossier

Episodes: 1
Verified stories: 1
Regions: US
Coverage signals: 9

Tracked from Aug 3, 2026 through Aug 3, 2026.

Daily, only when there is something new

Follow astrazeneca bristol myers squibb

Receive a concise digest after a new verified explanation publishes. Confirmation is required.

Interactive attention record

Latest episode

WITT Attention Index for astrazeneca bristol myers squibb in US. It combines a public traffic bucket, change in that bucket, attached coverage and cross-region presence.

View accessible data table

Observed	Traffic bucket	Attention Index
Aug 3, 00:10 UTC	1000+	56.0
Aug 3, 00:20 UTC	1000+	55.0
Aug 3, 00:30 UTC	2000+	67.6
Aug 3, 00:50 UTC	2000+	58.6

Episode history

ended US

August 3, 2026

Peak index: 68
Detected: 00:10 UTC
Status: ended

Read the verified explanation →

Verified explanations

ended Business 8 hours ago

AstraZeneca and Bristol Myers Squibb Explore Massive Pharmaceutical Merger Talks

Interest in AstraZeneca and Bristol Myers Squibb surged after multiple major outlets reported that the pharmaceutical giants held confidential merger discussions over several months. A combined entity would create one of the largest drugmakers in the world, though experts warn the deal would encounter intense regulatory scrutiny over overlapping cancer portfolios.

Index 0 US WITT Editorial Desk